CN108976122A - The method for preparing 1,3- dicarbonyl compound based on metal hydride/palladium compound system - Google Patents
The method for preparing 1,3- dicarbonyl compound based on metal hydride/palladium compound system Download PDFInfo
- Publication number
- CN108976122A CN108976122A CN201811070607.1A CN201811070607A CN108976122A CN 108976122 A CN108976122 A CN 108976122A CN 201811070607 A CN201811070607 A CN 201811070607A CN 108976122 A CN108976122 A CN 108976122A
- Authority
- CN
- China
- Prior art keywords
- compound
- palladium
- hydride
- metal hydride
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 25
- 229910052987 metal hydride Inorganic materials 0.000 title claims abstract description 22
- 150000004681 metal hydrides Chemical class 0.000 title claims abstract description 22
- 150000002941 palladium compounds Chemical class 0.000 title claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 28
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 21
- 230000002950 deficient Effects 0.000 claims abstract description 17
- 238000004440 column chromatography Methods 0.000 claims abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 14
- -1 alkene compound Chemical class 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 25
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 24
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 24
- 239000012312 sodium hydride Substances 0.000 claims description 24
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 10
- 229910000103 lithium hydride Inorganic materials 0.000 claims description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 5
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-Bis(diphenylphosphino)propane Substances C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 3
- 101150003085 Pdcl gene Proteins 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 3
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical group 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 12
- 239000001257 hydrogen Substances 0.000 abstract description 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 7
- 239000003054 catalyst Substances 0.000 abstract description 4
- 238000005984 hydrogenation reaction Methods 0.000 abstract description 3
- 150000004678 hydrides Chemical class 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 description 49
- 229930194542 Keto Natural products 0.000 description 46
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 32
- 150000002085 enols Chemical class 0.000 description 27
- 239000000243 solution Substances 0.000 description 19
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical group CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 235000019270 ammonium chloride Nutrition 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- WLWNRAWQDZRXMB-YLFCFFPRSA-N (2r,3r,4r,5s)-n,3,4,5-tetrahydroxy-1-(4-phenoxyphenyl)sulfonylpiperidine-2-carboxamide Chemical compound ONC(=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1S(=O)(=O)C(C=C1)=CC=C1OC1=CC=CC=C1 WLWNRAWQDZRXMB-YLFCFFPRSA-N 0.000 description 8
- 150000001336 alkenes Chemical class 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 238000002390 rotary evaporation Methods 0.000 description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 238000006228 Dieckmann condensation reaction Methods 0.000 description 2
- DIIWSYPKAJVXBV-UHFFFAOYSA-N Hantzch dihydropyridine Natural products CCOC(=O)C1=CC(C(=O)OCC)=C(C)N=C1C DIIWSYPKAJVXBV-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- LJXTYJXBORAIHX-UHFFFAOYSA-N diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1 LJXTYJXBORAIHX-UHFFFAOYSA-N 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 125000002092 orthoester group Chemical group 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
- PHDIJLFSKNMCMI-ITGJKDDRSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol Chemical compound OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)OCCCCCCCCOC=1C=C2C=CC=NC2=CC=1)O PHDIJLFSKNMCMI-ITGJKDDRSA-N 0.000 description 1
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了基于金属氢化物/钯化合物体系制备1,3‑二羰基化合物的方法,包括以下步骤,氮气保护下,把钯化合物和金属氢化物悬浮于溶剂中,然后加入缺电子烯化合物,在0℃~100℃下反应0.3~10小时,然后加入饱和氯化铵水溶液中止反应,然后萃取、蒸干、柱层析纯化,得到产物1,3‑二羰基化合物。本发明所用的氢化物和钯化合物催化剂都是实验室中容易获得的试剂,相比于常用的氢气氢化方法,此方法更易操作,安全性更高,条件温和,反应收率高。The invention discloses a method for preparing a 1,3-dicarbonyl compound based on a metal hydride/palladium compound system, comprising the following steps: suspending a palladium compound and a metal hydride in a solvent under nitrogen protection, and then adding an electron-deficient alkene compound, React at 0°C-100°C for 0.3-10 hours, then add saturated ammonium chloride aqueous solution to stop the reaction, then extract, evaporate to dryness, and purify by column chromatography to obtain the product 1,3-dicarbonyl compound. The hydride and palladium compound catalysts used in the present invention are reagents that are easily obtained in the laboratory. Compared with the commonly used hydrogen hydrogenation method, the method is easier to operate, has higher safety, mild conditions and high reaction yield.
Description
技术领域technical field
本发明属于有机合成技术领域,具体涉及金属氢化物/钯化合物体系在缺电子烯化合物Michael-Dieckmann串联反应中的应用,尤其涉及基于金属氢化物/钯化合物体系制备1,3-二羰基化合物的方法。The invention belongs to the technical field of organic synthesis, and specifically relates to the application of a metal hydride/palladium compound system in the Michael-Dieckmann series reaction of electron-deficient alkenes, and in particular to the preparation of 1,3-dicarbonyl compounds based on a metal hydride/palladium compound system method.
背景技术Background technique
氢化钠是一种实验室及工业上经常使用的强碱,长期以来,很少有做为还原剂被使用的相关报道。现有利用氢化钠的技术都需要大大过量的氢化钠(超过5当量),而且需要至少2当量的碘化钠做为促进剂。Sodium hydride is a strong base that is often used in laboratories and industries. For a long time, there have been few reports about its use as a reducing agent. Existing technologies utilizing sodium hydride all require a large excess of sodium hydride (more than 5 equivalents), and require at least 2 equivalents of sodium iodide as a promoter.
缺电子烯化合物的还原是一种常见的化学转化,生成相应的饱和的羰基化合物。这类反应一般是使用氢气/钯碳条件进行还原;另外,一些氢负试剂,比如[(Ph3P)CuH]6 (Stryker试剂)、R3SiH、Hantzsch 酯等也可以完成这种缺电子双键的还原。但是,这些还原条件要么具有一定的危险性,比如易爆炸的氢气;要么试剂较贵、反应缺乏原子经济性并且反应后需要处理较多的废弃物,比如[(Ph3P)CuH]6 (Stryker试剂)、R3SiH、Hantzsch 酯等。The reduction of electron-deficient alkenes is a common chemical transformation to the corresponding saturated carbonyl compounds. This type of reaction is generally reduced by hydrogen/palladium carbon; in addition, some hydrogen negative reagents, such as [(Ph 3 P)CuH] 6 (Stryker reagent), R 3 SiH, Hantzsch ester, etc. can also complete this electron-deficient Reduction of the double bond. However, these reducing conditions are either dangerous, such as explosive hydrogen gas; or the reagents are expensive, the reaction lacks atom economy, and more wastes need to be disposed of after the reaction, such as [(Ph 3 P)CuH] 6 ( Stryker reagent), R 3 SiH, Hantzsch ester, etc.
发明内容Contents of the invention
本发明要解决的技术问题是提供一种金属氢化物/钯化合物催化还原体系的应用,从而提供一种邻位酯基取代的缺电子烯化合物1进行Michael-Dieckmann串联反应,生成1,3-二羰基化合物3的方法。The technical problem to be solved in the present invention is to provide an application of a metal hydride/palladium compound catalytic reduction system, thereby providing an electron-deficient alkene compound 1 substituted by an ortho-ester group to perform a Michael-Dieckmann series reaction to generate 1,3- Method for dicarbonyl compounds 3.
本发明采用如下技术方案:The present invention adopts following technical scheme:
基于金属氢化物/钯化合物体系制备1,3-二羰基化合物的方法,包括以下步骤,氮气保护下,把钯化合物和金属氢化物悬浮于溶剂中,然后加入缺电子烯化合物,在0℃~100℃下反应0.3~10小时,得到1,3-二羰基化合物。The method for preparing a 1,3-dicarbonyl compound based on a metal hydride/palladium compound system comprises the following steps, under nitrogen protection, suspending the palladium compound and the metal hydride in a solvent, then adding an electron-deficient alkene compound, at 0° C. to React at 100°C for 0.3 to 10 hours to obtain 1,3-dicarbonyl compound.
本发明实现以上提及的串联反应(Michael-Dieckmann)的技术手段是以金属氢化物为还原剂,钯及其盐类为催化剂,以缺电子烯化合物为底物,在溶剂中反应得到串联产物1,3-二羰基化合物。The technical means of the present invention to realize the above-mentioned series reaction (Michael-Dieckmann) is to use metal hydride as a reducing agent, palladium and its salts as a catalyst, and an electron-deficient alkene compound as a substrate to react in a solvent to obtain a series product 1,3-dicarbonyl compounds.
本发明中,所述金属氢化物为氢化钠、氢化锂、氢化钾和氢化钙,优选氢化钠和氢化锂,更优选氢化钠。In the present invention, the metal hydrides are sodium hydride, lithium hydride, potassium hydride and calcium hydride, preferably sodium hydride and lithium hydride, more preferably sodium hydride.
本发明中,所述钯化合物为氯化钯、醋酸钯、Pd2(dba)3、Pd(TFA)2、[(η3-C3H5)PdCl]2、Pd(dppp)Cl2、Pd(C6H5CN)2Cl2、Pd(OH)2,优选氯化钯和醋酸钯,更优选氯化钯。In the present invention, the palladium compound is palladium chloride, palladium acetate, Pd 2 (dba) 3 , Pd(TFA) 2 , [(η 3 -C 3 H 5 )PdCl] 2 , Pd(dppp)Cl 2 , Pd(C 6 H 5 CN) 2 Cl 2 , Pd(OH) 2 , preferably palladium chloride and palladium acetate, more preferably palladium chloride.
氢化钠/钯进行Michael-Dieckmann串联反应有以下几点优势:1)相比于其它还原剂,氢化钠价格非常便宜;相比于氢气还原,氢化钠方法的安全性更高。2)氢化钠分子量小而且组成简单,反应中使用量少,所以用氢化钠做为还原剂是一种原子经济的方法;副产物除了无害的钠盐,没有其它废物产生。3)氢化钠和钯催化剂都是实验室常用的试剂,使用起来非常方便。4)相比于Stryker试剂,氢化钠/钯的组合价格要低廉很多,而且钯试剂可以回收利用,所以更适用于实验室和工业应用。The Michael-Dieckmann series reaction of sodium hydride/palladium has the following advantages: 1) Compared with other reducing agents, the price of sodium hydride is very cheap; compared with hydrogen reduction, the safety of sodium hydride method is higher. 2) Sodium hydride has a small molecular weight and simple composition, and is used in a small amount in the reaction, so using sodium hydride as a reducing agent is an atom-economical method; except for the harmless sodium salt, no other waste is produced as a by-product. 3) Sodium hydride and palladium catalysts are commonly used reagents in laboratories and are very convenient to use. 4) Compared with the Stryker reagent, the combination of sodium hydride/palladium is much cheaper, and the palladium reagent can be recycled, so it is more suitable for laboratory and industrial applications.
本发明中,缺电子烯化合物的化学结构式如下:In the present invention, the chemical structural formula of the electron-deficient alkene compound is as follows:
R为芳基、烷基、烷氧基、胺基等。R is an aryl group, an alkyl group, an alkoxy group, an amino group or the like.
本发明中,所述钯化合物、金属氢化物、缺电子烯化合物的摩尔比为(0.01~1) ∶(1~5) ∶1,优选的,所述钯化合物、金属氢化物、缺电子烯化合物的摩尔比为(0.05~0.15)∶(1~3) ∶1,更优选的,所述钯化合物、金属氢化物、缺电子烯化合物的摩尔比为0.1∶(1.5~2.5) ∶1,最更优选的,所述钯化合物、金属氢化物、缺电子烯化合物的摩尔比为0.1∶2∶1。In the present invention, the molar ratio of the palladium compound, metal hydride, and electron-deficient alkenes is (0.01~1):(1-5):1, preferably, the palladium compound, metal hydrides, electron-deficient alkenes The molar ratio of the compounds is (0.05-0.15): (1-3): 1, more preferably, the molar ratio of the palladium compound, the metal hydride, and the electron-deficient alkene compound is 0.1: (1.5-2.5): 1, Most preferably, the molar ratio of the palladium compound, the metal hydride, and the electron-deficient alkene compound is 0.1:2:1.
上述技术方案可表示如下:Above-mentioned technical scheme can be expressed as follows:
其中的R为芳基、烷基、烷氧基、胺基等;M为锂、钠、钾、钙等金属。Wherein R is an aryl group, an alkyl group, an alkoxy group, an amino group, etc.; M is a metal such as lithium, sodium, potassium, calcium, etc.
现有技术从化合物1到3的转化,可以分步完成,比如先用氢气还原双键,再用碱处理从而得到3;也可以使用Stryker试剂一锅串联完成,也就是先把1中的缺电子烯进行Michael类型的共轭还原、Dieckmann反应得到3;其中,分步反应操作复杂,成本较高,产生的废物多,一锅串联反应虽然简单,但是Stryker试剂非常昂贵(1g>500元),所以综合成本其实比分步法还要高。The conversion from compound 1 to compound 3 in the prior art can be completed step by step, for example, the double bond is first reduced by hydrogen, and then treated with alkali to obtain 3; it can also be completed by using Stryker reagent in one pot, that is, firstly remove the missing compound in 1. Electronene undergoes Michael-type conjugate reduction and Dieckmann reaction to obtain 3; among them, the step-by-step reaction is complicated to operate, the cost is high, and a lot of waste is generated. Although the one-pot series reaction is simple, the Stryker reagent is very expensive (1g>500 yuan) , so the comprehensive cost is actually higher than the footwork.
上述技术方案中,反应结束后加入饱和氯化铵水溶液中止反应,用溶剂萃取,蒸干,柱层析纯化,得到产物1,3-二羰基化合物。In the above technical scheme, after the reaction is completed, a saturated ammonium chloride aqueous solution is added to stop the reaction, extracted with a solvent, evaporated to dryness, and purified by column chromatography to obtain the product 1,3-dicarbonyl compound.
上述技术方案中,所述溶剂为DMA(N,N-二甲基乙酰胺)、DMF、THF、DME或者二氧六环。In the above technical solution, the solvent is DMA (N,N-dimethylacetamide), DMF, THF, DME or dioxane.
上述技术方案中,所述反应的温度优选25~60℃;所述反应的时间优选0.3~2小时。In the above technical solution, the reaction temperature is preferably 25-60° C.; the reaction time is preferably 0.3-2 hours.
从邻位酯基取代的缺电子烯化合物1制备1,3-二羰基化合物3,一般采用两类方法:一类是使用氢气/钯碳进行氢化还原双键,然后在碱性下发生Dieckmann缩合,在这个过程中,氢气的使用是一个潜在的危险因素,操作不当就会引起着火、爆炸;另一类是使用价格非常昂贵的Stryker试剂直接串联反应。所以本发明使用相对比较安全且价格低廉的金属氢化物用于Michael-Dieckmann串联反应具有重要的意义;而且更重要的是,此方法充分利用了氢化钠的还原性和碱性,是非常原子经济的方法。The preparation of 1,3-dicarbonyl compound 3 from the electron-deficient alkene compound 1 substituted by the ortho ester group generally adopts two types of methods: one is to use hydrogen gas/palladium carbon for hydrogenation to reduce the double bond, and then Dieckmann condensation under basic conditions , in this process, the use of hydrogen is a potential dangerous factor, and improper operation will cause fire and explosion; the other is to use very expensive Stryker reagents for direct series reactions. Therefore, the present invention uses relatively safe and cheap metal hydrides for the Michael-Dieckmann tandem reaction to be of great significance; Methods.
本发明所用的氢化物和钯化合物催化剂都是实验室中容易获得的试剂,相比于常用的氢气氢化方法,此方法更易操作,安全性更高,条件温和,反应收率高。The hydride and palladium compound catalysts used in the present invention are reagents that are easily obtained in the laboratory. Compared with the commonly used hydrogen hydrogenation method, the method is easier to operate, has higher safety, mild conditions and high reaction yield.
具体实施方式Detailed ways
实施例1Example 1
氮气保护下,氯化钯 (5.3 mg,0.03 mmol,10 mol%)和氢化钠 (60% in oil, 24 mg,0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3 mmol)在DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率>99%。Themixture of enol and keto form, enol/keto = 16/84. 1H NMR (400 MHz, CDCl3): δ10.37 (br, 1H, enol), 7.78 (d, J = 7.6 Hz, 1H), 7.63 (t, J = 7.2 Hz, 1H),7.53-7.35 (m, 2H), 3.86 (s, 3H, enol), 3.79 (s, 3H, keto), 3.74 (dd, J = 8.1,3.9 Hz, 1H, keto), 3.57 (dd, J = 17.3, 3.4 Hz, 1H, keto), 3.52 (s, 2H, enol),3.38 (dd, J = 17.2, 8.2 Hz, 1H, keto). 13C NMR (151 MHz, CDCl3): δ 199.58,169.68, 153.73, 143.33 (enol), 135.61, 135.32 (enol), 129.54 (enol), 127.97,126.97 (enol), 126.68, 124.86, 120.89, 102.30 (enol), 53.27, 52.95, 51.39(enol), 32.65 (enol), 30.40. LR-MS (ESI): m/z 191.2 [M+H]+。Under nitrogen protection, palladium chloride (5.3 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C for 5 minutes, Add a solution of compound 1a (0.3 mmol) in DMA (0.5 mL), then react at 25°C for 2 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, dry over sodium sulfate, and rotary evaporate Evaporated to dryness and purified by column chromatography, the product 3a was obtained with a yield of >99%. The mixture of enol and keto form, enol/keto = 16/84. 1 H NMR (400 MHz, CDCl 3 ): δ10.37 (br, 1H, enol), 7.78 (d, J = 7.6 Hz, 1H), 7.63 (t, J = 7.2 Hz, 1H), 7.53-7.35 (m, 2H), 3.86 (s, 3H, enol), 3.79 (s, 3H, keto), 3.74 (dd, J = 8.1, 3.9 Hz, 1H , keto), 3.57 (dd, J = 17.3, 3.4 Hz, 1H, keto), 3.52 (s, 2H, enol), 3.38 (dd, J = 17.2, 8.2 Hz, 1H, keto). 13 C NMR (151 MHz, CDCl 3 ): δ 199.58,169.68, 153.73, 143.33 (enol), 135.61, 135.32 (enol), 129.54 (enol), 127.97,126.97 (enol), 126.68, 124.86, 120.83, 2.3 (enol) 52.95, 51.39 (enol), 32.65 (enol), 30.40. LR-MS (ESI): m/z 191.2 [M+H]+.
实施例2Example 2
氮气保护下,醋酸钯 (2.7 mg, 0.015 mmol, 5 mol%)和氢化锂 (7.2 mg, 0.9 mmol,3.0 equiv)悬浮于DMF(1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3 mmol)在 DMF (0.5mL)的溶液,然后在100℃反应0.3小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率91%。Under nitrogen protection, palladium acetate (2.7 mg, 0.015 mmol, 5 mol%) and lithium hydride (7.2 mg, 0.9 mmol, 3.0 equiv) were suspended in DMF (1.5 mL), stirred at 25°C for 5 minutes, compound 1a (0.3 mmol ) in DMF (0.5mL), react at 100°C for 0.3 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, dry with sodium sulfate, evaporate to dryness by rotary evaporation, column chromatography After purification, the product 3a was obtained in a yield of 91%.
实施例3Example 3
氮气保护下,Pd2(dba)3 (2.7 mg, 0.003 mmol, 1 mol%)和氢化钾 (30% in oil,200 mg, 1.5 mmol, 5 equiv)悬浮于THF (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3mmol)在 THF (0.5 mL)的溶液,然后在0℃反应10小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率82%。Under nitrogen protection, Pd 2 (dba) 3 (2.7 mg, 0.003 mmol, 1 mol%) and potassium hydride (30% in oil, 200 mg, 1.5 mmol, 5 equiv) were suspended in THF (1.5 mL), stirred at 25°C For 5 minutes, add a solution of compound 1a (0.3mmol) in THF (0.5 mL), then react at 0°C for 10 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, and dry over sodium sulfate , evaporated to dryness by rotary evaporation, and purified by column chromatography to obtain product 3a with a yield of 82%.
实施例4Example 4
氮气保护下,Pd(TFA)2 (100 mg, 0.3 mmol, 100 mol%)和氢化钙 (24 mg, 0.6mmol, 2.0 equiv)悬浮于DME (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3 mmol)在DME (0.5 mL)的溶液,然后在90℃反应0.3小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率83%。Under nitrogen protection, Pd(TFA) 2 (100 mg, 0.3 mmol, 100 mol%) and calcium hydride (24 mg, 0.6 mmol, 2.0 equiv) were suspended in DME (1.5 mL), stirred at 25°C for 5 minutes, and compound 1a was added (0.3 mmol) in DME (0.5 mL), then reacted at 90°C for 0.3 hours, added saturated aqueous ammonium chloride solution to stop the reaction, extracted with ethyl acetate, combined the extracts, dried over sodium sulfate, and evaporated to dryness. Purified by column chromatography, the product 3a was obtained with a yield of 83%.
实施例5Example 5
氮气保护下,[(η3-C3H5)PdCl]2 (2.1 mg, 0.006 mmol, 2 mol%)和氢化钠(60% inoil, 12 mg, 0.30 mmol, 1.0 equiv)悬浮于二氧六环 (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3 mmol)在二氧六环 (0.5 mL)的溶液,然后在30℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率65%。Under nitrogen protection, [(η 3 -C 3 H 5 )PdCl] 2 (2.1 mg, 0.006 mmol, 2 mol%) and sodium hydride (60% inoil, 12 mg, 0.30 mmol, 1.0 equiv) were suspended in dioxane Ring (1.5 mL), stirred at 25°C for 5 minutes, added a solution of compound 1a (0.3 mmol) in dioxane (0.5 mL), then reacted at 30°C for 2 hours, added saturated aqueous ammonium chloride to stop the reaction, and washed with acetic acid Ethyl ester was extracted, the extracts were combined, dried over sodium sulfate, evaporated to dryness by rotary evaporation, and purified by column chromatography to obtain product 3a with a yield of 65%.
实施例6Example 6
氮气保护下,Pd(dppp)Cl2 (18 mg, 0.03 mmol, 10 mol%)和氢化钠 (60% in oil,24 mg, 0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3mmol)在 DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率63%。Under nitrogen protection, Pd(dppp)Cl 2 (18 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C Add compound 1a (0.3mmol) in DMA (0.5 mL) for 5 minutes, then react at 25°C for 2 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, and dry over sodium sulfate , evaporated to dryness by rotary evaporation, and purified by column chromatography to obtain product 3a with a yield of 63%.
实施例7Example 7
氮气保护下,Pd(C6H5CN)2Cl2 (11.4 mg, 0.03 mmol, 10 mol%)和氢化钠 (60% inoil, 24 mg, 0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1a(0.3 mmol)在 DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率77%。Under nitrogen protection, Pd(C 6 H 5 CN) 2 Cl 2 (11.4 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% inoil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL) , stirred at 25°C for 5 minutes, added a solution of compound 1a (0.3 mmol) in DMA (0.5 mL), then reacted at 25°C for 2 hours, added saturated aqueous ammonium chloride solution to stop the reaction, extracted with ethyl acetate, and combined the extracts, Dry over sodium sulfate, evaporate to dryness by rotary evaporation, and purify by column chromatography to obtain product 3a with a yield of 77%.
实施例8Example 8
氮气保护下,Pd(OH)2 (4.2 mg, 0.03 mmol, 10 mol%)和氢化钠 (60% in oil, 24mg, 0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1a (0.3mmol)在 DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3a,收率69%。Under nitrogen protection, Pd(OH) 2 (4.2 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C for 5 minutes , add a solution of compound 1a (0.3mmol) in DMA (0.5 mL), then react at 25°C for 2 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, dry with sodium sulfate, spin Evaporated to dryness and purified by column chromatography, the product 3a was obtained with a yield of 69%.
实施例9Example 9
氮气保护下,氯化钯 (5.3 mg,0.03 mmol,10 mol%)和氢化钠 (60% in oil, 24 mg,0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1b (0.3 mmol)在DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3b,收率98%。1H NMR(400 MHz, CDCl3): δ 7.69 (d, J = 7.6 Hz, 1H), 7.59-7.40 (m, 6H), 7.38-7.29(m, 2H), 3.74 (dd, J = 8.0, 4.3 Hz, 1H), 3.56 (dd, J = 16.9, 3.9 Hz, 1H),3.37 (s, 3H), 3.13 (dd, J = 16.8, 8.1 Hz, 1H). 13C NMR (151 MHz, CDCl3): δ202.19, 169.67, 154.41, 143.94, 135.80, 135.10, 129.94, 128.24, 127.95,127.61, 126.46, 124.42, 51.10, 37.92, 31.80. LR-MS (ESI): m/z 266.1 [M+H]+。Under nitrogen protection, palladium chloride (5.3 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C for 5 minutes, Add a solution of compound 1b (0.3 mmol) in DMA (0.5 mL), react at 25°C for 2 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, dry over sodium sulfate, and rotary evaporate Evaporated to dryness and purified by column chromatography, the product 3b was obtained with a yield of 98%. 1 H NMR(400 MHz, CDCl 3 ): δ 7.69 (d, J = 7.6 Hz, 1H), 7.59-7.40 (m, 6H), 7.38-7.29(m, 2H), 3.74 (dd, J = 8.0, 4.3 Hz, 1H), 3.56 (dd, J = 16.9, 3.9 Hz, 1H), 3.37 (s, 3H), 3.13 (dd, J = 16.8, 8.1 Hz, 1H). 13 C NMR (151 MHz, CDCl 3 ): δ202.19, 169.67, 154.41, 143.94, 135.80, 135.10, 129.94, 128.24, 127.95,127.61, 126.46, 124.42, 51.10, 37.92, 61.80. +.
实施例10Example 10
氮气保护下,氯化钯 (5.3 mg,0.03 mmol,10 mol%)和氢化钠 (60% in oil, 24 mg,0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1c (0.3 mmol)在DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3c,收率98%。Themixture of enol and keto form, enol/keto = 84/16. 1H NMR (400 MHz, CDCl3): δ7.81 (d, J = 7.6 Hz, 1H, enol), 7.72 (d, J = 7.6 Hz, 1H, keto), 7.63-7.46 (m,2H, enol and keto), 7.44-7.33 (m, 1H, enol and keto), 4.11-3.92 (m, 1H,keto), 3.77-3.68 (m, 1H, keto), 3.58 (s, 2H, enol), 3.12 (dd, J = 17.4, 7.7Hz, 1H, keto), 2.49 (s, 3H, keto), 2.17 (s, 3H, enol). 13C NMR (151 MHz,CDCl3): δ 201.52 (keto), 199.85 (keto), 191.56, 177.60, 154.24 (keto),147.63, 138.31, 135.52 (keto), 135.14 (keto), 132.88, 127.76 (keto), 127.43,126.73 (keto), 125.85, 124.61 (keto), 123.28, 110.56, 62.07 (keto), 30.38,29.82 (keto), 28.00 (keto), 21.18. LR-MS (ESI): m/z 175.1 [M+H]+。Under nitrogen protection, palladium chloride (5.3 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C for 5 minutes, Add a solution of compound 1c (0.3 mmol) in DMA (0.5 mL), then react at 25°C for 2 hours, add saturated aqueous ammonium chloride solution to stop the reaction, extract with ethyl acetate, combine the extracts, dry over sodium sulfate, and rotary evaporate Evaporated to dryness and purified by column chromatography, the product 3c was obtained with a yield of 98%. The mixture of enol and keto form, enol/keto = 84/16. 1 H NMR (400 MHz, CDCl 3 ): δ7.81 (d, J = 7.6 Hz, 1H, enol), 7.72 (d, J = 7.6 Hz , 1H, keto), 7.63-7.46 (m,2H, enol and keto), 7.44-7.33 (m, 1H, enol and keto), 4.11-3.92 (m, 1H,keto), 3.77-3.68 (m, 1H , keto), 3.58 (s, 2H, enol), 3.12 (dd, J = 17.4, 7.7Hz, 1H, keto), 2.49 (s, 3H, keto), 2.17 (s, 3H, enol ). (151 MHz, CDCl 3 ): δ 201.52 (keto), 199.85 (keto), 191.56, 177.60, 154.24 (keto), 147.63, 138.31, 135.52 (keto), 135.14 (keto), 132.88, 127.76 (keto), 127.76 (keto), ,126.73 (keto), 125.85, 124.61 (keto), 123.28, 110.56, 62.07 (keto), 30.38,29.82 (keto), 28.00 (keto), 21.18. LR-MS (ESI): m/z 175.1 [M+ H]+.
实施例11Example 11
氮气保护下,氯化钯 (5.3 mg,0.03 mmol,10 mol%)和氢化钠 (60% in oil, 24 mg,0.6 mmol, 2 equiv)悬浮于DMA (1.5 mL),25℃搅拌5分钟,加入化合物1d (0.3 mmol)在DMA (0.5 mL)的溶液,然后在25℃反应2小时,加入饱和氯化铵水溶液中止反应,用乙酸乙酯萃取,合并萃取液,用硫酸钠干燥,旋蒸蒸干,柱层析纯化,得到产物3d,收率99%。Themixture of enol and keto form, enol/keto = 87/13. 1H NMR (400 MHz, CDCl3): δ15.08 (br, 1H, enol), 8.14 (d, J = 7.6 Hz, 2H, keto), 8.00-7.92 (m, 2H,enol), 7.89 (d, J = 7.6 Hz, 1H, enol), 7.73 (d, J = 7.6 Hz, 1H, keto), 7.62-7.48 (m, 5H, enol and keto), 7.44 (t, J = 7.2 Hz, 1H, enol), 7.40-7.35 (m,1H, keto), 4.87 (dd, J = 7.4, 2.6 Hz, 1H, keto), 3.94 (s, 2H, enol), 3.90-3.75 (m, 1H, keto), 3.34 (dd, J = 17.1, 7.7 Hz, 1H, keto). 13C NMR (151 MHz,CDCl3): δ 200.12 (keto), 195.95, 194.40 (keto), 170.91, 154.47 (keto),148.70, 145.81 (keto), 138.03, 136.43 (keto), 135.41 (keto), 134.94 (keto),133.68 (keto), 133.47, 131.40, 129.96, 128.74, 128.25, 127.83 (keto), 127.59,126.65 (keto), 125.73, 124.77(keto), 123.57, 109.58, 56.69 (keto), 32.37,30.20 (keto). LR-MS (ESI): m/z 237.0 [M+H]+。Under nitrogen protection, palladium chloride (5.3 mg, 0.03 mmol, 10 mol%) and sodium hydride (60% in oil, 24 mg, 0.6 mmol, 2 equiv) were suspended in DMA (1.5 mL), stirred at 25°C for 5 minutes, Add a solution of compound 1d (0.3 mmol) in DMA (0.5 mL), react at 25°C for 2 hours, add saturated aqueous ammonium chloride to stop the reaction, extract with ethyl acetate, combine the extracts, dry over sodium sulfate, and rotary evaporate Evaporated to dryness and purified by column chromatography, the product 3d was obtained with a yield of 99%. The mixture of enol and keto form, enol/keto = 87/13. 1 H NMR (400 MHz, CDCl 3 ): δ15.08 (br, 1H, enol), 8.14 (d, J = 7.6 Hz, 2H, keto) , 8.00-7.92 (m, 2H, enol), 7.89 (d, J = 7.6 Hz, 1H, enol), 7.73 (d, J = 7.6 Hz, 1H, keto), 7.62-7.48 (m, 5H, enol and keto), 7.44 (t, J = 7.2 Hz, 1H, enol), 7.40-7.35 (m,1H, keto), 4.87 (dd, J = 7.4, 2.6 Hz, 1H, keto), 3.94 (s, 2H, enol), 3.90-3.75 (m, 1H, keto), 3.34 (dd, J = 17.1, 7.7 Hz, 1H, keto). 13 C NMR (151 MHz,CDCl 3 ): δ 200.12 (keto), 195.95, 194.40 (keto), 170.91, 154.47 (keto), 148.70, 145.81 (keto), 138.03, 136.43 (keto), 135.41 (keto), 134.94 (keto), 133.68 (keto), 133.47, 131.40, 129.98. 127.83 (keto), 127.59,126.65 (keto), 125.73, 124.77(keto), 123.57, 109.58, 56.69 (keto), 32.37,30.20 (keto). LR-MS (ESI): m/z 237.0 [M+H ]+.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811070607.1A CN108976122B (en) | 2018-09-13 | 2018-09-13 | Method for preparing 1,3-dicarbonyl compounds based on metal hydride/palladium compound system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811070607.1A CN108976122B (en) | 2018-09-13 | 2018-09-13 | Method for preparing 1,3-dicarbonyl compounds based on metal hydride/palladium compound system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108976122A true CN108976122A (en) | 2018-12-11 |
CN108976122B CN108976122B (en) | 2021-01-12 |
Family
ID=64545984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811070607.1A Active CN108976122B (en) | 2018-09-13 | 2018-09-13 | Method for preparing 1,3-dicarbonyl compounds based on metal hydride/palladium compound system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108976122B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020056565A1 (en) * | 2018-09-17 | 2020-03-26 | 南通纺织丝绸产业技术研究院 | Application of metal hydride/palladium compound system in preparation of 1,3-dicarbonyl compound in cascade reaction of electron-deficient alkene compound |
WO2020056564A1 (en) * | 2018-09-17 | 2020-03-26 | 南通纺织丝绸产业技术研究院 | Method for preparing 1,3-dicarbonyl compound based on metal hydride/palladium compound system |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010057865A1 (en) * | 2008-11-19 | 2010-05-27 | Glaxo Group Limited | N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators |
CN102491886A (en) * | 2011-12-01 | 2012-06-13 | 上海化工研究院 | Method for synthetizing indanone compound |
CN102863376A (en) * | 2012-09-27 | 2013-01-09 | 上海师范大学 | N-substituted methyl-3,5-disubstituted benzylidene base-4-piperidone and preparation method and application thereof |
WO2018079759A1 (en) * | 2016-10-31 | 2018-05-03 | 塩野義製薬株式会社 | Fused heterocycle having trka inhibitory activity and fused carbocycle derivative |
-
2018
- 2018-09-13 CN CN201811070607.1A patent/CN108976122B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010057865A1 (en) * | 2008-11-19 | 2010-05-27 | Glaxo Group Limited | N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators |
CN102491886A (en) * | 2011-12-01 | 2012-06-13 | 上海化工研究院 | Method for synthetizing indanone compound |
CN102863376A (en) * | 2012-09-27 | 2013-01-09 | 上海师范大学 | N-substituted methyl-3,5-disubstituted benzylidene base-4-piperidone and preparation method and application thereof |
WO2018079759A1 (en) * | 2016-10-31 | 2018-05-03 | 塩野義製薬株式会社 | Fused heterocycle having trka inhibitory activity and fused carbocycle derivative |
Non-Patent Citations (3)
Title |
---|
ITOH, TAKAHIRO ET AL.: "《1,4-Addition of arylboronic acids to β-aryl-α,β-unsaturated ketones and esters catalyzed by a rhodium(I)–chiraphos complex for catalytic and enantioselective synthesis of selective endothelin A receptor antagonists》", 《TETRAHEDRON》 * |
SASS, DAIANE CRISTINA ET AL.: "《Solvent Effect in Reactions Using Stryker"s Reagent》", 《JOURNAL OF ORGANIC CHEMISTRY 》 * |
丁刚等: "《钯催化的串联反应构建苯并五元杂环的研究进展》", 《有机化学》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020056565A1 (en) * | 2018-09-17 | 2020-03-26 | 南通纺织丝绸产业技术研究院 | Application of metal hydride/palladium compound system in preparation of 1,3-dicarbonyl compound in cascade reaction of electron-deficient alkene compound |
WO2020056564A1 (en) * | 2018-09-17 | 2020-03-26 | 南通纺织丝绸产业技术研究院 | Method for preparing 1,3-dicarbonyl compound based on metal hydride/palladium compound system |
US11180437B2 (en) | 2018-09-17 | 2021-11-23 | Soochow University | Method for preparing 1,3-dicarbonyl compound based on metal hydride/palladium compound system |
US11795132B2 (en) | 2018-09-17 | 2023-10-24 | Soochow University | Application of metal hydride/palladium compound system in preparation of 1,3-dicarbonyl compound in cascade reaction of electron-deficient alkene compound |
Also Published As
Publication number | Publication date |
---|---|
CN108976122B (en) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ye et al. | Synthesis of 2-aminopyridines via ruthenium-catalyzed [2+ 2+ 2] cycloaddition of 1, 6-and 1, 7-diynes with cyanamides: scope and limitations | |
CN109912606A (en) | A kind of synthetic method of pyrimidoindazole compound | |
CN110183341A (en) | 1,2- dicarbapentaborane class compound and its synthetic method | |
CN108976122A (en) | The method for preparing 1,3- dicarbonyl compound based on metal hydride/palladium compound system | |
CN108218672A (en) | Application of the metal compound/palladium compound catalytic reduction system in de- allyl reaction and deuterated reaction | |
CN108358760A (en) | Application of the metal compound/palladium compound catalytic reduction system in debenzylation and deuterated reaction | |
CN109053446B (en) | Application of Metal Hydride/Palladium Compound System in Tandem Reaction of Electron-deficient Alkenes to Prepare 1,3-Dicarbonyl Compounds | |
CN111320587A (en) | Preparation method of 1H-1,2, 3-triazole | |
CN109020864A (en) | Application and restoring method of the metal hydride/palladium compound catalytic reduction system in the reduction of alkenyl active methylene compound | |
US11420925B2 (en) | Reduction method and reduction product of alkenyl active methylene compound | |
US11180437B2 (en) | Method for preparing 1,3-dicarbonyl compound based on metal hydride/palladium compound system | |
CN109096105B (en) | Reduction method of alkenyl active methylene compound and reduction product | |
WO2020056565A1 (en) | Application of metal hydride/palladium compound system in preparation of 1,3-dicarbonyl compound in cascade reaction of electron-deficient alkene compound | |
CN109020865B (en) | 3,3-Disubstituted indole oxide and preparation method thereof | |
WO2020051853A1 (en) | 3,3-disubstituted oxindole and preparation method thereof | |
CN104774202A (en) | Synthesis method of 9H-pyridino[2,3-b]indole compounds | |
CN105237466B (en) | A kind of method for synthesizing three substituted pyridine derivatives | |
CN114349656A (en) | A kind of preparation method of hydrazide compound | |
WO2020051854A1 (en) | Use of metal hydride/palladium compound catalytic reduction system in reduction of alkenyl active methylene compound and reduction method | |
CN107098844B (en) | A kind of synthetic method for the acyl indol quinoline class compound that C-5 nitro replaces | |
CN116375602B (en) | A method for photochemically synthesizing benzyl nitrile using arylthianthrene salts | |
CN111995543B (en) | A kind of synthetic method of α-ketoamide compound | |
CN117142916B (en) | Preparation method of allyl sulfone compound | |
CN107501180B (en) | Synthesis method of quinoline-4-formamide compound | |
CN112500324B (en) | Method for preparing thioamide compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |